GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan YZY Biopharma Co Ltd (HKSE:02496) » Definitions » Median PS Value

Wuhan YZY Biopharma Co (HKSE:02496) Median PS Value : HK$0.00 (As of Apr. 12, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Wuhan YZY Biopharma Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Wuhan YZY Biopharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.594. Wuhan YZY Biopharma Co's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is HK$0.00.

As of today (2025-04-12), Wuhan YZY Biopharma Co's share price is HK$5.90. Wuhan YZY Biopharma Co's Median PS Value is HK$0.00. Therefore, Wuhan YZY Biopharma Co's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Wuhan YZY Biopharma Co's Median PS Value or its related term are showing as below:

HKSE:02496's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.64
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Wuhan YZY Biopharma Co Median PS Value Historical Data

The historical data trend for Wuhan YZY Biopharma Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan YZY Biopharma Co Median PS Value Chart

Wuhan YZY Biopharma Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Median PS Value
- - - -

Wuhan YZY Biopharma Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Median PS Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of Wuhan YZY Biopharma Co's Median PS Value

For the Biotechnology subindustry, Wuhan YZY Biopharma Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan YZY Biopharma Co's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan YZY Biopharma Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Wuhan YZY Biopharma Co's Price-to-Median-PS-Value falls into.


;
;

Wuhan YZY Biopharma Co Median PS Value Calculation

Wuhan YZY Biopharma Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.594*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wuhan YZY Biopharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.594.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan YZY Biopharma Co  (HKSE:02496) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Wuhan YZY Biopharma Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=5.90/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan YZY Biopharma Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Wuhan YZY Biopharma Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan YZY Biopharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 666 Gaoxin Road, East Lake High Tech, Development Zone, Hubei Province, Wuhan, CHN
Wuhan YZY Biopharma Co Ltd is a biotechnology company specifically involved in developing bispecific antibody-based therapies to treat cancer or cancer-associated complications, cancer and age-related ophthalmologic diseases to address medical demands in oncology and aging-related ophthalmologic disease areas, The Company has been operating in one reportable segment, being the discovering, developing and commercializing a new class of medicines in respect to anti-tumor bispecific antibody. It generates the majority of its revenue from PRC.
Executives
Wen Zhicheng 2201 Interest of corporation controlled by you
Guo Hong Wei
Dragon Merit Holdings Limited 2201 Interest of corporation controlled by you
Shi Yao Ji Tuan En Bi Pu Yao Ye You Xian Gong Si 2101 Beneficial owner
Cspc Pharmaceutical Group Limited 2201 Interest of corporation controlled by you
Robust Sun Holdings Limited 2201 Interest of corporation controlled by you
Wang Hongjie 2201 Interest of corporation controlled by you
He Bei Yi Er Qi Ye Guan Li Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Mei Shan Bao Shui Gang Qu Guang Rui Hong Xiang Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Guo Xin Si Chuang Tou Zi Ji Jin Guan Li Bei Jing You Xian Gong Si 2201 Interest of corporation controlled by you
Nan Jing Cai Zhi Er Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Cdh 2018 Vgc Investment Fund, L.p. 2201 Interest of corporation controlled by you
Nan Ning Hui You Xing Yao Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Nan Ning Yao You Shang Wu Zi Xun He Huo Qi Ye You Xian He Huo
Wen Zhi Cheng

Wuhan YZY Biopharma Co Headlines

No Headlines